Benefit and risk from paclitaxel-coated balloon angioplasty for the treatment of femoropopliteal artery disease: A systematic review and meta-analysis of randomised controlled trials
Sign Up to like & getrecommendations! Published in 2019 at "EClinicalMedicine"
DOI: 10.1016/j.eclinm.2019.09.004
Abstract: Background Paclitaxel-coated balloons (DCB) are suitable to reduce the risk of restenosis after angioplasty of atherosclerotic femoropopliteal lesions. However, numerous types of DCBs are distinguished by drug density and coating. Conflicting evidence exists about the… read more here.
Keywords: balloon angioplasty; risk; treatment femoropopliteal; treatment ... See more keywords
Endovascular treatment of femoropopliteal arterial occlusive disease: Current techniques and limitations.
Sign Up to like & getrecommendations! Published in 2022 at "Seminars in vascular surgery"
DOI: 10.1053/j.semvascsurg.2022.04.010
Abstract: In an aging population with a rising incidence of peripheral artery disease, endovascular therapy is a favorable alternative to open surgical bypass. As a minimally invasive approach, endovascular therapy incurs less physiologic stress and periprocedural… read more here.
Keywords: endovascular therapy; disease; endovascular treatment; treatment femoropopliteal ... See more keywords